Completeness of adverse drug reactions reports of the Saudi adverse event reporting system

References

1. ↵
   1. Saudi Food & Drug Authority

   Establishment of A General Authority for Food and Drug. Available from URL: http://www.sfda.gov.sa/ar/about/Pages/memo.aspx. Updated 2013. Accessed 2014 May 12.
2. ↵
   1. Olsson S

   Kick-off for pharmacovigilance in Saudi Arabia. UR45 UPPSALA reports. Available from URL: http://who-umc.org/graphics/24355.pdf. Cited 2009 April; Accessed 2012 May 12.
3. ↵
   1. World Health Organization

   Pharmacovigilance. Available from URL: http://www.who.int/medicines/areas/quality_safety/safety_efficacy/pharmvigi/en/. Cited 2014; Accessed 2014 July 12.
4. ↵
   1. Meyboom RH,
   2. Egberts AC,
   3. Gribnau FW,
   4. Hekster YA

   (1999) Pharmacovigilance in perspective. Drug Saf 21:429–447.

   OpenUrlPubMed
5. ↵
   1. Jacob D,
   2. Marron B,
   3. Ehrlich J,
   4. Rutherford PA

   (2013) Pharmacovigilance as a tool for safety and monitoring: A review of general issues and the specific challenges with end-stage renal failure patients. Drug Healthc Patient Saf 5:105–112.

   OpenUrl
6. ↵
   1. Saudi Food & Drug Authority

   The National Pharmacovigilance and Drug Safety Center. Available from URL: http://www.sfda.gov.sa/en/drug/about/sector_departments/national_pharmacovigilance_center//pages/reporting_forms.aspx. Cited: 2012; Accessed: 2012 May 12.
7. ↵
   1. Alshammari T,
   2. Syed R,
   3. Swartz L,
   4. Hammad T

   (2009) Comparison of adverse drug reactions (ADRS) reports submitted to the FDA by consumers and healthcare professionals (HCPs). Pharmacoepidemiol Drug Saf 18:S1–S273.

   OpenUrlCrossRefPubMed
8. ↵
   1. Aagaard L,
   2. Nielsen LH,
   3. Hansen EH

   (2009) Consumer reporting of adverse drug reactions: A retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006. Drug Saf 32:1067–1074.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Thiessard F,
   2. Roux E,
   3. Miremont-Salame G,
   4. Fourrier-Reglat A,
   5. Haramburu F,
   6. Tubert-Bitter P,
   7. et al.

   (2005) Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001). Drug Saf 28:731–740.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    1. Meyboom RH,
    2. Egberts AC,
    3. Edwards IR,
    4. Hekster YA,
    5. de Koning FH,
    6. Gribnau FW

    (1997) Principles of signal detection in pharmacovigilance. Drug Saf 16:355–365.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Rossi AC,
    2. Knapp DE,
    3. Anello C,
    4. O’Neill RT,
    5. Graham CF,
    6. Mendelis PS,
    7. et al.

    (1983) Discovery of adverse drug reactions. A comparison of selected phase iv studies with spontaneous reporting methods. JAMA 249:2226–2228.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    1. Begaud B,
    2. Martin K,
    3. Fourrier A,
    4. Haramburu F

    (2002) Does age increase the risk of adverse drug reactions? Br J Clin Pharmacol 54:550–552.

    OpenUrlCrossRefPubMedWeb of Science
13. 1. Routledge PA,
    2. O’Mahony MS,
    3. Woodhouse KW

    (2004) Adverse drug reactions in elderly patients. Br J Clin Pharmacol 57:121–126.

    OpenUrlCrossRefPubMedWeb of Science
14. 1. Carbonin P,
    2. Pahor M,
    3. Bernabei R,
    4. Sgadari A

    (1991) Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 39:1093–1099.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    1. Nguyen JK,
    2. Fouts MM,
    3. Kotabe SE,
    4. Lo E

    (2006) Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 4:36–41.

    OpenUrlCrossRefPubMed
16. ↵
    1. Wester K,
    2. Jonsson A,
    3. Spigset O,
    4. Hagg S

    (2007) Spontaneously reported fatal suspected adverse drug reactions: A 10-year survey from Sweden. Pharmacoepidemiol Drug Saf 16:173–180.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    1. Wallerstedt SM,
    2. Brunlof G,
    3. Sundstrom A

    (2011) Rates of spontaneous reports of adverse drug reactions for drugs reported in children: A cross-sectional study with data from the Swedish adverse drug reaction database and the Swedish prescribed drug register. Drug Saf 34:669–682.

    OpenUrlPubMed
18. ↵
    1. Brajovic S,
    2. Piazza-Hepp T,
    3. Swartz L,
    4. Dal Pan G

    (2012) Quality assessment of spontaneous triggered adverse event reports received by the food and drug administration. Pharmacoepidemiol Drug Saf 21:565–570.

    OpenUrlCrossRefPubMed
19. ↵
    1. Aagaard L,
    2. Christensen A,
    3. Hansen EH

    (2010) Information about adverse drug reactions reported in children:A qualitative review of empirical studies. Br J Clin Pharmacol 70:481–491.

    OpenUrlCrossRefPubMed
20. ↵
    1. Wu TY,
    2. Jen MH,
    3. Bottle A,
    4. Molokhia M,
    5. Aylin P,
    6. Bell D,
    7. et al.

    (2010) Ten-year trends in hospital admissions for adverse drug reactions in england 1999-2009. J R Soc Med 103:239–250.

    OpenUrlCrossRefPubMed
21. ↵
    1. Davies EC,
    2. Green CF,
    3. Taylor S,
    4. Williamson PR,
    5. Mottram DR,
    6. Pirmohamed M

    (2009) Adverse drug reactions in hospital in-patients:A prospective analysis of 3695 patient-episodes. PLoS One 4:e4439.

    OpenUrlCrossRefPubMed